[DOI] [PubMed] [Google Scholar] 39.Rhodes S.D., He Y., Smith A., Jiang L., Lu Q., Mund J., Li X., Bessler W., Qian S., Dyer W., et al
However, clinical trials have been known to show that tirzepatide can be a significant factor in lessening the risk of type 2 diabetes by up to 10 years in people with overweight or obesity
However, the rationale for their concurrent use is supported by their complementary mechanisms of action and the clinical benefits observed in treating coexisting conditions such as obesity and depression
Dizziness that is persistent throughout the day for more than two weeks without any improvement, despite addressing hydration, nutrition, and positioning habits, deserves a clinical assessment to rule out non-medication causes
Teriparatide (Forteo): Builds bone for osteoporosis [3]
Many PlexusDx patients find that after 6-12 months at goal weight on a stable dose, their confidence in maintaining eating patterns increases significantly